Here we present the case of 15-year-old boy with intrathoracic SS who relapsed after standard chemotherapy, surgery and radiotherapy: molecular analysis identified a BRAF V600E mutation at progression of relapsed disease under third line systemic treatment. This evidence concerns the gene BRAF and synovial sarcoma.